1Matilde Todaro,Miriam Gaggianesi,Veronica Catalano,Antonina Benfante,Flora Iovino,Mauro Biffoni,Tiziana Apuzzo,Isabella Sperduti,Silvia Volpe,Gianfranco Cocorullo,Gaspare Gulotta,Francesco Dieli,Ruggero De Maria,Giorgio Stassi.CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis[J]. Cell Stem Cell . 2014 (3)
2Pavel Pitule,Miroslava Cedikova,Ondrej Daum,Jan Vojtisek,Ondrej Vycital,Petr Hosek,Vladislav Treska,Ondrej Hes,Milena Kralickova,Vaclav Liska,Georgios Tsoulfas.Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients[J]. BioMed Research International . 2014
3Jae Jun Park,Ji‐hee Kwon,Sun‐Hee Oh,Junjeong Choi,Chang Mo Moon,Joong Bae Ahn,Sung Pil Hong,Jae Hee Cheon,Tae Il Kim,Hoguen Kim,Won Ho Kim.Differential expression of CD133 based on microsatellite instability status in human colorectal cancer[J]. Mol. Carcinog. . 2014 (S1)
4Kelly M. Flynn,Michael Michaud,Sandra Canosa,Joseph A. Madri.CD44 regulates vascular endothelial barrier integrity via a PECAM-1 dependent mechanism[J]. Angiogenesis . 2013 (3)
5Marcus Langenski?ld,Marie-Lois Ivarsson,Lena Holmdahl,Peter Falk,Christina K?bj?rn-Gustafsson,Eva Angenete.Intestinal mucosal MMP-1 – a prognostic factor in colon cancer[J].Scandinavian Journal of Gastroenterology.2013(5)
6N. E. Kushlinskii,E. S. Gershtein,E. A. Korotkova,V. V. Prorokov.Prognostic Role of Tumor-Associated Proteases in Colorectal Cancer[J]. Bulletin of Experimental Biology and Medicine . 2013 (3)
7Swetha Sundararajan,Subash Babu,Sulochana D. Das.Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients[J]. Human Immunology . 2012 (10)
8Ulrich Richter,Daniel Wicklein,Silvana Geleff,Udo Schumacher.The interaction between CD44 on tumour cells and hyaluronan under physiologic flow conditions: implications for metastasis formation[J]. Histochemistry and Cell Biology . 2012 (5)
9R. Kopp,M. Fichter,G. Schalhorn,J. Danescu,S. Classen.Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variantin colorectal adenomas and carcinomas[J]. International Journal of Molecular Medicine . 2009 (5)
10Andro Tripkovic,Ingrid Tripkovic,Snjezana Tomic.THE ROLE OF nm23 GENE IN COLORECTAL CARCINOGENESIS. ACTA CLINICA CROATICA . 2012
2Simeoni L,Posevitz V,Kolsch U,et al.The transmembrane adapter protein SIT regulates thymic development and peripheral Tcell functions[J].Mol Cell Biol,2005,25(17):7557-7568.
3Kawakami Y.Cancer treatment by comprehensive regulation of anti-tumor immune network[J].Nihon Rinsho,2010,68(6):1094.
4Kacani L,Wurm M,Schennach H,et al.Immunosuppressive effects of soluble factors secreted by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes[J].Oral Oncol,2003,39(7):672-679.
5Chouailb S,Thiery J,Gati A,et al.Tumor escape from killer inhibitory receptors and acquisition of tumor resistance to cell death[J].Tissue Antigens,2002,60(4):273-281.
6Yacyshyn MB,Poppema S,Berg A,et al.CD69+and HLA-DR+activion antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients:correlations with survival following active specific immunotherapy[J].Int J Cancer,1995,61(4):470.
7Mlecnik B,Tosolini M,Kirilovsky A,et al.Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction[J].J Clin Oncol,2011,29(6):610-618.
8Galon J,Costes A,Sanchez-Cabo F,et al.Type,density,and location of immune cells within human colorectal tumors predict clinical outcome[J].Science,2006,313(5795):1960-1964.
9Frederick DT,Piris A,Cogdill AP,et al.BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma[J].Clin Cancer Res,2013,19(5):1225-1231.
10Galluzzi L,Vacchelli E,Eggermont A,et al.Trial Watch:Adoptive cell transfer immunotherapy[J].Oncoimmunology,2012,1(3):306-315.
